Sponsor or institution

Clinical trials and research at TCRx Therapeutics Co.Ltd

• 8Clinical trials
• 1Country

Newest trials

All recruiting trials (8)

• Apheresis Collection for New Drug Development and Evaluation (PBMCs)

  This observational study will collect peripheral blood mononuclear cells (PBMCs) from about 200 adults aged 18–40 to create cell samples for research.

  Recruiting TCRx Therapeutics Co.Ltd · Bengbu, Anhui and 1 other locations · NCT07663565

• KXV01 Injection for Advanced Solid Tumors

  A single-arm, early-stage test to see if KXV01 TCR Lentinvivo is safe and tolerable and to get a first look at any signs it might help patients with advanced solid tumors.

  Recruiting Phase 1 TCRx Therapeutics Co.Ltd · Shanghai · NCT07596693

• Personalized KXV01 TCR Lentivivo Injection for Advanced Solid Tumors

  A single-center, early-phase study will test a personalized T cell therapy delivered in vivo to see if it is safe and may help people with advanced solid tumors who have exhausted other options.

  Recruiting Phase 1 TCRx Therapeutics Co.Ltd · Beijing · NCT07275853

• KSV01 injection for relapsed or refractory diffuse large B‑cell lymphoma

  This trial will test a new injectable treatment called KSV01 in adults with relapsed or refractory diffuse large B‑cell lymphoma to see if it is safe and can help control the cancer.

  Recruiting Phase 1 TCRx Therapeutics Co.Ltd · Wuhan, Hubei · NCT07260812

• Personalized KXV01 TCR Lentinvivo Injection for Advanced Solid Tumors

  A first-in-human, single-arm study tests a KXV01 TCR lentiviral treatment given in vivo to see if it is safe and tolerable for adults with advanced solid cancers that have exhausted standard therapies.

  Recruiting Phase 1 TCRx Therapeutics Co.Ltd · Hefei, Anhui · NCT07196579

• Injection of TCR-T cells for treating solid tumors

  This study tests if a new injection of TCR-T cells can help people with hard-to-treat solid tumors feel better and live longer.

  Recruiting Early Phase 1 TCRx Therapeutics Co.Ltd · Nanning, Guangxi · NCT05811975

• Treatment for solid tumors using engineered T-cells

  This study is testing a new treatment using specially engineered T-cells to see if they can help people with certain types of solid tumors feel better.

  Recruiting Early Phase 1 TCRx Therapeutics Co.Ltd · Beijing, Beijing Municipality · NCT05580796

• Treatment using TCR-T cells for patients with advanced solid tumors

  This study is testing a new treatment using TCR-T cell therapy to see if it can help patients with advanced solid tumors that haven't responded to other treatments.

  Recruiting Early Phase 1 TCRx Therapeutics Co.Ltd · Nanning, Guangxi · NCT05539833

Quick answers

How many clinical trials run by TCRx Therapeutics Co.Ltd are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Early Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →